Immunterapi

CLINICAL RESEARCH. Six Swedish university hospitals are now accepting patients in a unique randomized study that will hopefully improve the prognosis for patients with metastasized melanoma. The study is being led by the University of Gothenburg and Sahlgrenska University Hospital and is examining whether survival after immunotherapy can be improved by removing remaining metastases. “Today, we do not know whether survival can be improved by removing metastases surgically. Unfortunately, metastatic…